Intrinsic Bioprobes, Inc.

Intrinsic Bioprobes Inc. (IBI) is a privately held biotechnology company that develops innovative technologies for rapid and sensitive proteomics and biomarker analysis. IBI applies its innovations through protein analysis services and research partnerships. Organizations working with IBI can accelerate their drug development cycles, increase the efficacy of therapies in development, and reduce bottom line expenses.